ArticleCardiovascular diabetology2025

Prevalence and thrombotic risk of SGLT-2 inhibitor-associated erythrocytosis: a retrospective cohort study.

Ji Yun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.